Phase III trial of methyl aminolevulinate for the treatment of moderate to severe acne.

Trial Profile

Phase III trial of methyl aminolevulinate for the treatment of moderate to severe acne.

Planning
Phase of Trial: Phase III

Latest Information Update: 10 Apr 2015

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Acne
  • Focus Registrational; Therapeutic Use
  • Sponsors PhotoCure
  • Most Recent Events

    • 10 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top